We conduct a thorough assessment of the current reimbursement environment to uncover both potential challenges and strategic opportunities for your device. This includes a detailed review of existing coverage pathways, payment mechanisms, and financial incentives that may influence adoption. We also identify key stakeholders—such as payers, policy influencers, and clinical decision-makers—who shape access and reimbursement decisions. By mapping the landscape early, we help you anticipate barriers and position your product for success across targeted markets.
We develop a comprehensive, step-by-step plan to secure reimbursement for your medical technology, starting with a clearly defined value proposition that resonates with payers. This includes building robust economic models, aligning clinical evidence with coverage criteria, and identifying the most viable coding and payment pathways. By integrating reimbursement strategy early in the product development cycle, we help ensure that commercial viability is built into your innovation from the outset—reducing risk and accelerating access.
We help determine the most appropriate billing codes—such as HCPCS, CPT, or proprietary pathways—for your device, ensuring alignment with clinical use and payer expectations. When existing codes are insufficient, we guide you through the application process for new code creation, including documentation, stakeholder engagement, and submission strategy. Accurate coding is critical not only for proper billing and reimbursement, but also for enabling provider adoption and long-term market viability. Our approach ensures your coding strategy is both technically sound and commercially strategic.
We actively engage with payers to advocate for favorable coverage policies that support patient access and commercial success. This includes presenting compelling clinical and economic evidence to demonstrate the device's value, aligning with payer priorities, and navigating the nuances of both private and public insurance systems. Whether negotiating with commercial insurers or government programs, we help shape coverage decisions that reflect the innovation and impact of your technology—ensuring your product is positioned for long-term reimbursement viability.
Advancing medical device innovation requires more than breakthrough technology—it demands strategic alignment with payer expectations, regulatory milestones, and clinical value. This section highlights how evidence-backed devices are positioned for market access, reimbursement, and adoption. From diagnostics to therapeutic platforms, each solution is evaluated for impact, coded for clarity, and supported with data that drives coverage and accelerates patient access.
We provide strategic guidance on pricing that reflects the clinical and economic value of your device while remaining viable for payers, providers, and procurement channels. This includes analyzing market dynamics, benchmarking competitor pricing, and assessing willingness-to-pay across different segments. Our approach ensures that pricing decisions are grounded in both commercial realities and reimbursement potential—supporting sustainable access, provider adoption, and long-term growth.
We collaborate with healthcare providers, payers, and key influencers to build understanding and alignment around your device’s clinical and economic value. This includes developing tailored educational materials, conducting targeted training sessions, and facilitating dialogue that supports reimbursement readiness. By proactively engaging stakeholders, we help ensure that your technology is not only understood but also supported across the access ecosystem—laying the groundwork for smoother adoption and sustained coverage.
Poplar Access Advisors aligns regulatory strategy with reimbursement planning from day one—ensuring every clinical and evidence decision supports a clear path to coverage, coding, and payment. Our team integrates FDA, CMS, and commercial payer perspectives to create synchronized launch strategies that accelerate time to revenue and minimize access risk. By bridging regulatory milestones with payer expectations, we help medtech innovators design smarter trials, secure stronger value narratives, and achieve faster market adoption.
We provide hands-on support to help your device navigate the complexities of market entry and payer engagement. This includes coordinating pilot projects with individual payers, securing prior authorizations, and managing denial appeals to resolve access barriers. Our approach ensures that your technology is not only clinically validated but also operationally supported across payer systems. By addressing these critical touchpoints early, we help accelerate adoption, reduce friction, and position your product for scalable reimbursement success.
Our advisors combine policy insight, health economics expertise, and payer engagement strategies to deliver measurable results for clients bringing transformative therapies to market.
Develop global value proposition, pricing and Reimbursement strategy for continuous glucose monitoring and remote patient monitoring solutions
Drive reimbursement, including coding and payment, Payer engagement, clinical evidence strategy to support Local Coverage Determination (LCD) and value demonstration. Establish billing department
Drive alignment of regulatory, clinical and reimbursement strategies to minimize time to coverage post FDA clearance. Support CEO in funding activities.
Drive reimbursement and prior authorization for advanced interventions, including implantable spinal cord stimulation and novel neurostimulation approaches.
Strategic commercial and reimbursement support for pricing and distribution for behavioral health technology.
Drive Reimbursement activities for surgical line of business in Europe and Middle East
Whether you're navigating reimbursement for a novel device, preparing for payer engagement, or aligning FDA and coverage strategy, this is where strategic clarity begins. Engage directly with a partner who’s launched wearables globally, secured coding and payment pathways, and supported investor due diligence from the inside. Tailored for MedTech teams in wearables, digital health, neuromodulation, and diagnostics, this lifeline offers more than advice—it's responsive, founder-led counsel built for speed, credibility, and outcomes.
Contact